脑中的中风样损伤不仅导致损伤部位的细胞死亡,而且导致中风周围区域的其他有害结构和分子变化。中风诱导的脂质分布改变干扰神经元功能,例如神经传递。防止这些不利的变化对于恢复很重要。已知罗勒圣药(Tulsi提取物)具有抗炎和神经保护特性。Tulsi可能通过将活性成分亲脂性转移到大脑中而赋予神经保护作用。因此,我们研究了在给予Tulsi提取物后,患有光血栓性-缺血性-中风样损伤的小鼠的大脑皮质和血浆中脂质分布的变化.Tulsi提取物中存在的脂质也可能有助于活性成分的亲脂性转移到脑中。因此,为了鉴定Tulsi提取物中的主要脂质种类,我们对Tulsi提取物进行了代谢组学和非靶向脂质组学分析。在Tulsi提取物中检测到39种分子脂质的存在。然后,我们在小鼠模型中检查了使用Tulsi提取物治疗对光血栓性缺血性中风后大脑和血浆的非靶向脂质组学特征的影响。C57Bl/6j菌株的小鼠,年龄2-3个月,随机分为四组:(I)假,(ii)病变,(iii)病变加Tulsi,和(iv)病变加布洛芬。使用Q-Exactive质谱仪收集受损大脑半球的大脑皮层和血浆样品用于非靶向脂质组学分析。我们的结果记录了主要脂质组的显着变化,包括PE,PC,中性甘油脂,PS,和P-甘油,在用Tulsi治疗后,光血栓形成性中风小鼠的大脑和血浆样本中。在进一步比较不同的小鼠研究组之间,MGDG水平(36:4),这可能有助于恢复,当与其他组相比时,发现在用Tulsi处理的小鼠的脑皮质中增加(p<0.05)。脂质种类,如PS,PE,液化石油气,在假手术和病变加Tulsi组中,PI通常会改变。来自Sham组的大脑样本特别富含许多种类的甘油类脂,并且减少了PE种类,与病变组相比,他们的血浆样本显示PE和PS物种发生了变化。在Tulsi提取物中发现LPC(16:1),并且在PTL加Tulsi处理组的脑中显著增加。我们的结果表明,Tulsi对脑缺血的神经保护作用可能部分与其调节大脑和血浆脂质的能力有关,这些结果可能有助于为脑缺血或脑损伤的治疗选择提供重要的见解。
Stroke-like injuries in the brain result in not only cell death at the site of the injury but also other detrimental structural and molecular changes in regions around the stroke. A stroke-induced alteration in the lipid profile interferes with neuronal functions such as neurotransmission. Preventing these unfavorable changes is important for recovery. Ocimum sanctum (
Tulsi extract) is known to have anti-inflammatory and neuroprotective properties. It is possible that
Tulsi imparts a neuroprotective effect through the lipophilic transfer of active ingredients into the brain. Hence, we examined alterations in the lipid profile in the cerebral cortex as well as the plasma of mice with a photothrombotic-ischemic-stroke-like injury following the administration of a Tulsi extract. It is also possible that the lipids present in the Tulsi extract could contribute to the lipophilic transfer of active ingredients into the brain. Therefore, to identify the major lipid species in the Tulsi extract, we performed metabolomic and untargeted lipidomic analyses on the
Tulsi extract. The presence of 39 molecular lipid species was detected in the
Tulsi extract. We then examined the effect of a treatment using the Tulsi extract on the untargeted lipidomic profile of the brain and plasma following photothrombotic ischemic stroke in a mouse model. Mice of the C57Bl/6j strain, aged 2-3 months, were randomly divided into four groups: (i) Sham, (ii) Lesion, (iii) Lesion plus Tulsi, and (iv) Lesion plus Ibuprofen. The cerebral cortex of the lesioned hemisphere of the brain and plasma samples were collected for untargeted lipidomic profiling using a Q-Exactive Mass Spectrometer. Our results documented significant alterations in major lipid groups, including PE, PC, neutral glycerolipids, PS, and P-glycerol, in the brain and plasma samples from the photothrombotic stroke mice following their treatment with Tulsi. Upon further comparison between the different study groups of mice, levels of MGDG (36:4), which may assist in recovery, were found to be increased in the brain cortexes of the mice treated with Tulsi when compared to the other groups (p < 0.05). Lipid species such as PS, PE, LPG, and PI were commonly altered in the Sham and Lesion plus Tulsi groups. The brain samples from the Sham group were specifically enriched in many species of glycerol lipids and had reduced PE species, while their plasma samples showed altered PE and PS species when compared to the Lesion group. LPC (16:1) was found in the
Tulsi extract and was significantly increased in the brains of the PTL-plus-
Tulsi-treated group. Our results suggest that the neuroprotective effect of Tulsi on cerebral ischemia may be partially associated with its ability to regulate brain and plasma lipids, and these results may help provide critical insights into therapeutic options for cerebral ischemia or brain lesions.